Annovis Bio, Inc.’s Post

Just published on Frontiers in Drug Safety and Regulation: a disrupting article by VitroScreen in collaboration with Biocodex  that shows that in vitro advanced models can make the difference in the biological evaluation of Medical Devices. Together with Biocodex we have worked on a big plan to demonstrate that, to reduce and replace animal models to demonstrate the MoA of MD testing is possible, and our approach has been accepted by the scientific community. Thanks to Barbara De Servi, Francesco Carriero, Francesca Rescigno for their excellent work and, to the whole Biocodex team! Read the full article: https://lnkd.in/dANcZsQB #MoA #Invitroadvancedmodels #MedicalDeviceRegulation #VitroScreen #Biocodex

Capsida’s Chakameh Azimpour, Ph.D will be presenting a poster at the 2024 PDA Advanced Therapy Medicinal Products Conference:   📅 Date: 24-25 June 2024 📍 Location: Amsterdam, The Netherlands   The poster, entitled "Development of a dual reporter cargo and systemic incorporation of a highly flexible, benchtop automation system to facilitate rAVV9 based novel capsid development and characterization," showcases innovative research that highlights the breadth of Capsida’s analytical development expertise in characterizing novel engineered capsids.   This work is a collaborative effort by a talented team of Capsida researchers: Paul Denis, Kevin Chu, Jesse Granados, Regan Sobaje, Claire S., Leandro Fernandez, Tiffany Morrison, Lysa-Anne Volpe, Chakameh Azimpour, Ph.D.   Well done to the whole team!   #AdvancedTherapies #PDAConference #CapsidDevelopment #BiotechInnovation #ScientificResearch #AutomationInScience #GeneTherapy #ATMP #AdvancedTherapyMedicinalProduct  

All workflows of HiOmics

In our upcoming Coffee Chat in partnership with SCIEX, three experts will take a look at the technologies that have made drug discovery excel and the advancements that may be coming soon. Save your seat for the 22nd of May >>> https://hubs.ly/Q02v2HGT0

Omics experiments produce lots of data points and expose potential target-disease relationships. However, a foundational model is then critical to more deeply understand and evidence these relationships. This evidence then empowers more confident target selection and related #drugdiscovery research decisions. If you would like to learn more about how Biorelate provides the best evidence for foundational models, visit www.biorelate.com

Have you read Issue 42 of Nanographia, the quarterly newsletter from The McCrone Group? Never miss an issue—follow the link, then hit the Subscribe button in the upper left corner of your browser window. https://lnkd.in/gS8rG3A5 #microscopy #materialsanalysis #pharmaceuticalmanufacturing #DrugDevelopment

This summer, Biorelate celebrates a 10-year anniversary as a company. Among many proud achievements in this decade, we host what is now the world-leading knowledge graphs in biopharma conference, an event we have kept free-of-charge and in virtual (webinar) format to ensure everyone in the biopharma research community can access it. We're celebrating this achievement by spotlighting 10x use cases shared in this conference series. Today, check out 'Moving from information retrieval to knowledge graphs' from Nikola Milosevic where abbreviation expansion, FAIR normalisation, relationship extraction and the challenges of named entity and ontologies are addressed, among other critical knowledge graph building foundations. Watch the recording >> https://lnkd.in/eWpEtRE4

Every clinical research project has a unique set of challenges. That’s why LabConnect offers a full suite of innovative Central Laboratory Services that are designed to meet the unique needs of your #clinicaltrial – of any size and complexity. With access to more global points of service than any other central lab, discover how LabConnect makes it easy to keep your research moving forward. => https://lnkd.in/dJe82SXN #CentralLab #DrugDevelopment #LabConnect

Are you ready for a paradigm shift in blood collection? Clinical Lab Chat talked with Bridget Bagnato, worldwide president, Specimen Management for BD, about the BD MiniDraw™ Capillary Blood Collection System, the future of blood collection and the potential for a major shift in the industry that would impact patients, clinicians and labs: https://lnkd.in/eTDi56Wj #BD #bloodcollection #ClinicalLabChat

🎃 Happy Halloween! 🎃 Are you haunted by the fear of missing critical cellular phenotypes due to those ghostly fix-and-wash steps? 👻 Fear no more! Saguaro's ChromaLIVE is here to save the day (and your data) with its mix-and-read, single-step, no-wash dye—actively used by over 100 pharma innovators. It’s helping uncover thrilling new phenotypes across drug discovery pipelines! 🧪✨ Across different platforms, data has shown ChromaLIVE offers better recall and precision than traditional fixed stains. So, why let your cells get spooked by old methods? Explore our non-toxic, live-cell dye options to take your imaging to the next level... no tricks, just treats! 🍬🔬 https://lnkd.in/dPg8hw2V #HappyHalloween #LiveCellImaging #DrugDiscovery #Phenotypicprofiling #ChromaLIVE #Livecellpainting